In this study, the improvement of anemia in CKD rats by JPYS treatment and the involvement of HIF signaling in JPYS-treated rats, including renal functions, hematological parameters, and EPO concentrations, as well as HIF activation, were investigated. The gene discussed is EPO; the disease is chronic kidney disease.